A randomized comparative study assessing once versus twice a day treatment of benign prostatic hyperplasia with terazosin

We compared the efficacy of once a day administration of terazosin hydrochloride with that of twice a day administration for benign prostatic hyperplasia (BPH) patients. Forty-two patients with BPH were randomly assigned to receive a maximum dose of 2 mg terazosin either once (n = 21) or twice (n =...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 47(2001), 2 vom: 01. Feb., Seite 77-81
1. Verfasser: Suzuki, H (VerfasserIn)
Weitere Verfasser: Ohnishi, T, Ikemoto, I, Ohishi, Y, Suzuki, Y, Yamazaki, H
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2001
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial English Abstract Journal Article Multicenter Study Randomized Controlled Trial Adrenergic alpha-Antagonists Terazosin 8L5014XET7 Prazosin XM03YJ541D